Ruxolitinib |
20-abx076799 |
Abbexa |
|
|
|
Human IgG antibody Laboratories manufactures the invivogen: ruxolitinib reagents distributed by Genprice. The Invivogen: Ruxolitinib reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact InVivoGen. Other Invivogen: products are available in stock. Specificity: Invivogen: Category: Ruxolitinib
Ruxolitinib phosphate |
ApexBio |
25 mg |
EUR 268.8 |
Description: INCB018424 (Ruxolitinib) is an orally bioavailable JAK inhibitor .(IC50 values for JAK1, JAK2 and JAK3 are 3, 5 and 332 nM, respectively).INCB018424 is useful for rheumatoid arthritis. |
Ruxolitinib phosphate |
ApexBio |
5 mg |
EUR 157.2 |
Description: INCB018424 (Ruxolitinib) is an orally bioavailable JAK inhibitor .(IC50 values for JAK1, JAK2 and JAK3 are 3, 5 and 332 nM, respectively).INCB018424 is useful for rheumatoid arthritis. |
Ruxolitinib phosphate |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 135.6 |
Description: INCB018424 (Ruxolitinib) is an orally bioavailable JAK inhibitor .(IC50 values for JAK1, JAK2 and JAK3 are 3, 5 and 332 nM, respectively).INCB018424 is useful for rheumatoid arthritis. |
EZSolution? Ruxolitinib |
Biovision |
each |
EUR 261.6 |
INCB018424 (Ruxolitinib) |
EnoGene |
5mg |
EUR 625.2 |
Chemicals information
Ruxolitinib . phosphate salt |
10-043 |
ProSci |
25 mg |
EUR 387.96 |
Description: Water-soluble phosphate salt of Ruxolitinib. Antineoplastic, anti-inflammatory and immunomodulating agent. Orally bioavailable potent ATP mimetic that inhibits both JAK1 and JAK2 with IC50 values of 2.7 and 4.5nM, respectively and is less selective for JAK3 (IC50=322nM). Affects DC differentiation and function, leading to impaired T cell activation. Used in the treatment of myeloproliferative neoplasms and psoriasis. Anticancer agent. Shown to induce apoptosis and autophagy. Potent and selective inhibitor of HIV-1 replication and virus reactivation in vitro. It is investigated against the spread of the SARS-CoV-2 (COVID-19) |
Ruxolitinib (JAK kinase inhibitor) |
SIH-509-25MG |
Stressmarq |
25 mg |
EUR 750 |
|
Description: The substance Ruxolitinib is a jak kinase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is off-white solid which is soluble in DMSO (25 mg/ml) or EtOH (~15 mg/ml). |
Ruxolitinib (JAK kinase inhibitor) |
SIH-509-5MG |
Stressmarq |
5 mg |
EUR 285.6 |
|
Description: The substance Ruxolitinib is a jak kinase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is off-white solid which is soluble in DMSO (25 mg/ml) or EtOH (~15 mg/ml). |
GFP-lacZ (His) Lentiviral particles, invivo ready |
LVP021-PBS |
GenTarget |
5x107 IFU/ml x 200ul |
EUR 1034.4 |
Description: Pre-made lentiviral particles expressing GFP-LacZ fusion gene with C-term His tag. A RFP was bicistronically expressed under the same suCMV promoter. Concentrated Particles are provided in PBS solution. |
S-Ruxolitinib (INCB018424) |
A4149-1 |
ApexBio |
1 mg |
EUR 277.2 |
Description: S-Ruxolitinib is the chirality of INCB018424, is a potent and selective small-molecule Janus kinase 1 (JAK1) and JAK2 inhibitor. It was initially developed to target the constitutive activation of the JAK-STAT pathway. |
S-Ruxolitinib (INCB018424) |
A4149-5 |
ApexBio |
5 mg |
EUR 514.8 |
Description: S-Ruxolitinib is the chirality of INCB018424, is a potent and selective small-molecule Janus kinase 1 (JAK1) and JAK2 inhibitor. It was initially developed to target the constitutive activation of the JAK-STAT pathway. |
S-Ruxolitinib (INCB018424) |
A4149-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 367.2 |
Description: S-Ruxolitinib is the chirality of INCB018424, is a potent and selective small-molecule Janus kinase 1 (JAK1) and JAK2 inhibitor. It was initially developed to target the constitutive activation of the JAK-STAT pathway. |
Recombinant Mouse TECTB Protein, His, Invitro-E.coli-10ug |
QP9985-iv-10ug |
EnQuireBio |
10ug |
EUR 936 |
Recombinant Mouse TECTB Protein, His, Invitro-E.coli-50ug |
QP9985-iv-50ug |
EnQuireBio |
50ug |
EUR 554.4 |
ODN 2041-Non-CpG ODN. Invitro control for rabbit cells. Antigen grade |
ODN2041-1 |
Alpha Diagnostics |
1 mg |
EUR 781.2 |
Recombinant Mouse TECTB Protein, His, Invitro-E.coli-100ug |
QP9985-iv-100ug |
EnQuireBio |
100ug |
EUR 1424.4 |
Recombinant Human PSAP A1 Protein, His-B2M, Invitro-E.coli-10ug |
QP10005-iv-10ug |
EnQuireBio |
10ug |
EUR 554.4 |
Recombinant Human PSAP A1 Protein, His-B2M, Invitro-E.coli-50ug |
QP10005-iv-50ug |
EnQuireBio |
50ug |
EUR 936 |
Recombinant Human PSAP A2 Protein, His-B2M, Invitro-E.coli-10ug |
QP10008-iv-10ug |
EnQuireBio |
10ug |
EUR 554.4 |
Recombinant Human PSAP A2 Protein, His-B2M, Invitro-E.coli-50ug |
QP10008-iv-50ug |
EnQuireBio |
50ug |
EUR 936 |
Recombinant Human CD19/ Leu-12 Protein, His, Invitro-E.coli-10ug |
QP5782-iv-10ug |
EnQuireBio |
10ug |
EUR 979.2 |
Recombinant Human CD19/ Leu-12 Protein, His, Invitro-E.coli-50ug |
QP5782-iv-50ug |
EnQuireBio |
50ug |
EUR 619.2 |